1. P96 Repeat Administration of GL67A/pGM169 is Feasible, Safe, and Produces Endogenous Levels of CFTR Expression After 12 Doses. (19th November 2012) Authors: Alton, EWFW; Boyd, AC; Cheng, SH; Davies, J; Davies, LA; Dayan, A; Gill, DR; Griesenbach, U; Higgins, T; Hyde, SC; Innes, A; McLachlan, G; Porteous, D; Pringle, IA; Scheule, RK; Sumner-Jones, SG Journal: Thorax Issue: Volume 67(2012)Supplement 2 Page Start: A105 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗